Form D · Other

MedaSync Inc.

Cleveland, OH · CIK 0001755049

Offering snapshot reported Aug 17, 2026 · SEC filing

Reported sold
$2.12M
Offering amount: $2.12M
Investors reported
18
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 16, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.06M$2.12MAug 8, 2025: $1,569,676.00Aug 8, 2025Aug 17, 2026: $2,119,676.00Aug 17, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,569,676 → $2,119,676

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 17, 2026Amendment$2,119,676$550,000vs Aug 8, 202518SEC filing
Aug 8, 2025Initial$1,569,676No comparison18SEC filing
Oct 19, 2018Initial$550,000No comparison6SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-554135

Source: Form D, filed Aug 17, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Megan Ames Director
Ryan Edgerly Director, Executive
Gene Groys Director
Ernie Knight Director
Ernest Knight Director
Charlie Lougheed Director
Harvey Sass Director

Issuer details

Industry: Other (See others in industry)

Address:
2800 Euclid Ave Ste. 225
Cleveland, OH, 44115